ATHEROGENICS INC
10-Q, EX-27.1, 2000-09-07
PHARMACEUTICAL PREPARATIONS
Previous: ATHEROGENICS INC, 10-Q, 2000-09-07
Next: TYCOM LTD, 10-Q, 2000-09-07



<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT
OF 1934 FOR THE QUARTERLY PERIOD ENDED JUNE 30, 2000.
</LEGEND>

<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-START>                             JAN-01-2000
<PERIOD-END>                               JUN-30-2000
<CASH>                                       8,677,290
<SECURITIES>                                         0
<RECEIVABLES>                                1,055,924
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                            10,235,600
<PP&E>                                       1,751,468
<DEPRECIATION>                                       0
<TOTAL-ASSETS>                              12,170,656
<CURRENT-LIABILITIES>                        3,864,781
<BONDS>                                              0
                       39,604,288
                                          0
<COMMON>                                    14,310,226
<OTHER-SE>                                 (45,738,724)
<TOTAL-LIABILITY-AND-EQUITY>                12,170,656
<SALES>                                              0
<TOTAL-REVENUES>                             4,155,330
<CGS>                                                0
<TOTAL-COSTS>                                        0
<OTHER-EXPENSES>                            10,927,635
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                            (294,299)
<INCOME-PRETAX>                             (6,478,006)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                                  0
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                (6,478,006)
<EPS-BASIC>                                      (2.33)
<EPS-DILUTED>                                    (2.33)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission